Covishield

Wednesday, May 29, 2024 | Last Update : 12:24 AM IST

Vaccine hesitancy, fueled by misinformation, can lead to preventable disease outbreaks. (PTI Photo/Swapan Mahapatra)

Chandrakant Lahariya | All vaccines have minimal, but rare risks; don’t worry over Covishield

Historical vaccine skepticism continues to impact public health, emphasizing the importance of accurate information.

04 May 2024 11:46 PM

This will be in addition to the existing guidelines for homologous precaution dose administration of Covaxin and Covishield vaccine. (Representational image: ANI)

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

This is for the first time that a booster dose that is different from the one used for primary vaccination against Covid has been allowed

10 Aug 2022 12:23 PM

A municipal corporation worker shows vials of COVID-19 vaccine before administering to beneficiaries, at a KMC health centre in Kolkata. (Photo:PTI)

Two COVID vaccines may cost Rs. 275 after market nod

The National Pharmaceutical Pricing Authority (NPPA) has already been directed to start working towards capping the price

27 Jan 2022 6:59 AM

With no deaths in the last 24 hours reported in the union territory, the death toll in Andaman and Nicobar stands at 129. (AP Photo)

COVID-19: Andaman and Nicobar Islands achieve 100 pc vaccination coverage

The total cases of the COVID-19 infection have moved up to 7,701 including two active cases

19 Dec 2021 1:06 PM

COVAX officials have started planning allocations of the Covishield shot for various countries. (Photo: PTI/File)

India could ship vaccines to COVAX in a few weeks, say sources

WHO, which co-leads COVAX, has been urging India to restart supplies for the programme

09 Nov 2021 12:31 PM

Covishield, the India-manufactured Oxford-AstraZeneca COVID-19 vaccine, was added to the UK's approved list last month. (PTI)

UK to add Covaxin to approved vaccine list from November 22

The move follows the World Health Organisation's Emergency Use Listing for Covaxin, which is the second most used formulation in India

09 Nov 2021 11:40 AM

A health worker holds the used vials of Covishield vaccine during a special vaccination drive in the outskirts of Jammu. (Photo: PTI/File)

India committed to supplying COVID-19 vaccines to other nations by year end

India had suspended exports of COVID-19 vaccines in April

25 Oct 2021 1:54 PM

A health worker holds the used vials of Covishield vaccine during a special vaccination drive in the outskirts of Jammu. (Photo: PTI)

Covishield may offer over 90% protection against death from Delta variant: Study

The study is the first to show how effective vaccines are at preventing death from the Delta variant

21 Oct 2021 12:30 PM

A vial of Covishield, an Indian made vaccine for COVID-19, lies at a vaccination center set up at a government run school in Bengaluru. (Photo: AP/File)

Covishield approved by Australia for international arrivals

The recognition of the vaccines will remove a significant barrier for international students seeking to study in Australia

01 Oct 2021 11:33 AM

A health worker prepares a dose of the Covishield vaccine against the Covid-19 coronavirus at a vaccination centre in Ahmedabad. (Photo: AFP)

UK adds Covishield to approved vaccines list in updated travel advisory

The move follows widespread condemnation of the SII-manufactured vaccines not being included in a list of eligible vaccines

22 Sep 2021 2:30 PM

People get inoculated with the dose of the Covaxin Covid-19 coronavirus vaccine at a temporary vaccination camp inside a school in Mumbai. (Indranil MUKHERJEE / AFP)

'Number of people who got at least one dose of COVID jab in India highest in world'

Presently, about 60.7 per cent of the adult population in the country has received at least one dose of COVID-19 vaccine, the ministry said

15 Sep 2021 10:48 AM

A health worker administers the vaccine for COVID-19 at District Govt Women's Hospital in Varanasi. (Photo: AP)

India logs 45,083 new COVID-19 cases

The death toll has climbed to 4,37,830 with 460 fresh fatalities

29 Aug 2021 10:17 AM

The report also quoted other studies that have reported a reduction in neutralisation among Covishield and Covaxin vaccine beneficiaries after infection with the Delta variant. (Representational image: AP)

ICMR study in Chennai shows vaccination reduces mortality due to Delta variant

The prevalence of the Delta variant or B.1.617.2 was not different between the vaccinated and un-vaccinated groups

19 Aug 2021 1:00 PM

A recent study by the Indian Council of Medical Research (ICMR) involving 98 people showed that combining these two COVID-19 vaccines elicited better immunogenicity than two doses of the same vaccine. (Representational image: AFP)

India's drug regulator approves study on mixing of Covaxin and Covishield doses

An expert panel of the Central Drugs Standard Control Organisation on July 29 had recommended granting permission for conducting the study

11 Aug 2021 11:36 AM

The mixing and matching of Covid-19 vaccines may possibly do more good than harm, a study conducted by the Indian Council of Medical Research has claimed. (Representational Photo:AP)

ICMR: Cocktail of Covaxin, Covishield is ‘safe, better’

The study was done by ICMR on 18 individuals who were inadvertently given a shot of Covaxin after their first dose of the Covishield in UP

09 Aug 2021 12:41 AM

Johnson & Johnson will further boost the country's collective fight against the novel coronavirus infection. (Reuters/File Photo)

Johnson & Johnson's single-dose COVID-19 vaccine gets Emergency Use approval in India

The 5 vaccines granted EUA in India are SI's Covishield, Bharat Biotech's Covaxin, Russia's Sputnik V, Moderna and now Johnson & Johnson

07 Aug 2021 2:37 PM

A health worker prepares to inoculates a man with a dose of the Covishield vaccine against the Covid-19 coronavirus. (Photo: AFP)

CII-Serum Institute to work to expand vaccination across small towns, rural areas

CII undertook a survey with responses from over 3,000 companies in 196 cities

30 Jul 2021 1:14 PM

Domestic vaccine manufacturers are given the option to provide 25 per cent of their monthly production of vaccines to private hospitals. (Representational Photo: AFP)

Govt to procure 66 crore more doses of Covishield, Covaxin at revised rates

The price of each dose of Covishield amounts to Rs 215.25 and Covaxin Rs 225.75, including taxes

17 Jul 2021 12:53 PM

Javelin thrower Neeraj Chopra who qualified for Tokyo Olympics. (DC File Photo)

Sports Ministry seeks MEA assistance to complete vaccination of 7 overseas athletes

It is likely that the Indians athletes and the support staff will get their second doses in the Indian missions in those countries

05 Jul 2021 6:59 PM

A Tokyo Metropolitan Government employee takes the Moderna's COVID-19 vaccine shot at a newly opened vaccination center in the government building in Tokyo. (Photo: AP)

Will one dose of a two-dose COVID-19 vaccine protect me?

There’s a concern the shots eventually might lose their effectiveness if variants evolve enough

02 Jul 2021 1:02 PM

There have been apprehensions in India that people who took Covishield and Covaxin jabs are unlikely to be eligible to travel to the European Union member states under its 'Green Pass' scheme. (AP Photo)

Nine European countries accepting Covishield for travel from India

India has already asked the EU member countries to individually consider allowing Indians who have taken Covishield and Covaxin vaccines

01 Jul 2021 6:51 PM

Under this framework, persons who have taken vaccines authorised by the European Medicines Agency (EMA) will be exempted from travel restrictions within the EU. (PTI Photo)

India requests EU to consider Covishield, Covaxin jabs under Green passport scheme

The sources said the genuineness of such vaccination certification can be authenticated on the CoWIN portal

30 Jun 2021 9:17 PM

The Union health ministry will facilitate the supply of these vaccines to the private hospitals after payment is made. (Photo: PTI/File)

Private hospitals need to place orders on CoWIN to procure vaccines from July 1

Most hospitals have already registered on the portal, sources stated

30 Jun 2021 12:26 PM

'Mixed' schedules of these vaccines induced high concentrations of antibodies against the SARS-CoV2 spike IgG protein when doses were administered four weeks apart. (Photo: Representational/PTI)

Oxford study says mixing COVID-19 vaccines gives good protection

The University of Oxford is leading the Com-COV study, run by the National Immunisation Schedule Evaluation Consortium

29 Jun 2021 8:55 AM

The Centre informed about the projected availability of COVID-19 vaccines in an affidavit filed in the suo motu case. (Photo: PTI/File)

135 crore vaccine doses to be available between August-Dec: Centre to Supreme Court

Out of these, the estimated availability of Covishield doses is 50 crores, while of Covaxin doses is 40 crores

27 Jun 2021 11:58 AM

Karan Thapar | Mind the gap: Covishield’s 2nd jab sets off controversy

Paradoxically, three days after India’s May decision, and because of the threat of the Delta variant, the UK reduced the gap to eight weeks

25 Jun 2021 12:40 AM

A medic holds a vial of Bharat Biotech's covid vaccine, Covaxin. (Photo: AFP)

Over 2.58 crore Covid vaccine doses still available with states: Centre

Of this, the total consumption, including wastage is 25,32,65,825 doses, the ministry said

18 Jun 2021 3:24 PM

The NTAGI chairman also stated that Canada, Sri Lanka and few other countries are using 12 - 16 weeks interval for the AstraZeneca vaccine which is the same as the Covishield vaccine. (ANI)

Decision to increase gap between Covishield doses based on scientific evidence: NTAGI

Dr Arora said that the earlier decision of four weeks was based upon the bridging trial data available then

16 Jun 2021 12:45 PM

Researchers at Public Health Scotland and the University of Edinburgh, UK, found that the Pfizer-BioNTech vaccine offered better protection against the Delta variant compared to the Oxford-AstraZeneca preventive. (AFP)

Pfizer, AstraZeneca vaccines protect against Delta variant: Lancet study

Pfizer vaccine offered 92 per cent protection against the Alpha variant and 79 per cent against the Delta strain 2 weeks after the 2nd dose

15 Jun 2021 1:11 PM

A medic administers a dose of COVID-19 vaccine to a man, at Nair hospital in Mumbai, Monday, June 14, 2021. (PTI Photo)

Covid recovered people need only one dose of vaccine: AIG Study

The study concluded that the single dose of vaccine does offer protection and creates the immune memory required to fight the virus

15 Jun 2021 12:45 AM

Health workers administer COVID-19 vaccine doses to shopkeepers at a market in Bhopal, Tuesday, June 8, 2021. (PTI Photo)

Centre places order for 44 cr doses of COVID-19 vaccines

AIIMS director said there is no data to show that children will be seriously infected in subsequent Covid-19 waves

09 Jun 2021 1:35 AM

Prime Minister Shri Narendra Modi addresses the nation in New Delhi. (Photo: PTI)

Centre to provide free vaccine to states for those over 18 yrs from June 21: PM Modi

The Centre has decided to buy 75 per cent of jabs from vaccine makers

07 Jun 2021 9:28 PM

The conclusion of the study said that both the vaccines have shown elicited good immune response. (Photo: PTI)

Covishield produced more antibodies than Covaxin, says preliminary study

The study is a preprint and has not been peer-reviewed

07 Jun 2021 1:14 PM

Flagging several other flaws in its vaccine policy -- including shortage of vaccine doses and problems faced by rural people in accessing vaccines -- the court also directed the Centre to give an outline for “how and when the Central government seeks to vaccinate the remaining population in phases 1, 2 and 3” . — PTI

SC slams Centre’s vaccination policy as ‘irrational’, asks for purchase data

The top court also sought data on the percentage of population that has been vaccinated (with one dose and both doses)

03 Jun 2021 1:03 AM

A health worker collects swab sample of a passenger at a COVID-19 testing counter at New Delhi railway station, on May 25, 2021.

COVID cases, positivity rate take a dip in Delhi, but black fungus a big worry

The Centre said that India was the second country after the United States to cross 20 crore cumulative Covid-19 vaccination coverage

27 May 2021 2:37 AM

The AEFI Committee’s in-depth case review of 498 serious and severe events found 26 cases to be potential thromboembolic events following the administration of Covishield vaccine. (Representational Image/AFP)

Reporting of vaccination adverse effects made hugely difficult, going unreported

It is important for the government to take AEFI tracking more seriously and aggressively as it is doing for vaccination

23 May 2021 1:16 PM

We can reach a national jab rate of 10 million (one crore) a day, which means vaccinating the country in 4-5 months. (AP file photo)

Probal DasGupta | India can vaccinate swiftly by using ‘mohalla method’

A swifter pace of vaccinations is the antidote to arrest fatality numbers, build confidence and encourage a quicker economic revival

19 May 2021 6:54 AM

Govt ready to allow other companies to make Covaxin

The government has now engaged five Public Sector Undertakings to help increase production of Covaxin

14 May 2021 12:00 AM

The stock of Covaxin in Delhi has finished. (Photo: AP)

Serum says will raise monthly production to 10 crore doses by August

Sources said Health Ministry and the office of DCGI had sought from both the firms their production plan for June, July, August, September

12 May 2021 10:43 PM

Any overzealous, though well-meaning judicial intervention may lead to unforeseen and unintended consequences in absence of any expert advice, the Centre told the top court. — AFP

Differential vaccine pricing is right, Centre tells Supreme Court

Government defends move, says it is to incentivise vaccine makers

11 May 2021 7:54 AM

Under India's Vaccine Maitri' initiative, which translates into Vaccine Friendship, the country has been providing vaccines to nations across the world (Representational image: AP)

India's gift of 200,000 COVID vaccine doses will be sent to UN peacekeepers on Mar 27

More than 58 million Made in India coronavirus vaccine doses have reached about 70 countries in the recent weeks

26 Mar 2021 11:40 AM

Senior officials in the Union health ministry said there is no need to panic as the government has ensured that there is no shortage of Covid-19 vaccines in the country. (PTI file photo)

COVID-19 surge: Passengers to Bengaluru will now need a negative test report

Several other states have also started imposing restrictions on movement of people

26 Mar 2021 1:51 AM

The Centre has purchased 11 million doses of Covishield vaccine for the ongoing inoculation drive. (Photo: AP)

Serum Institute applies for trials of another Covid-19 vaccine

The firm has already produced Covishield vaccine, co-developed by the University of Oxford and British-Swedish company AstraZeneca

31 Jan 2021 12:27 AM

The government must at least now do a rethink on the campaign and be true and honest with the people on its components. It must win people’s confidence by placing all the facts before them, to start with; piecemeal and ad hoc release of critical information is not the right way to do it. (Photo:AFP)

AA Edit | Put politics, profit aside; level with all on vaccine

The government and the companies should have been upfront about the products from the beginning

23 Jan 2021 12:00 AM

A nurse, right, performs rituals to a box containing COVID-19 vaccines upon its arrival at a government Hospital in Ahmedabad, India, Saturday, Jan. 16, 2021. (AP /Ajit Solanki)

AA Edit | Transparency the key to success of vaccine drive

If a vaccine is under trial and has not gone through the due process, its administration should be called clinical trial, not vaccination

18 Jan 2021 12:10 AM

Paracetamol may be used to provide symptomatic relief from post vaccination adverse reactions. (PTI/file)

Pregnant, lactating women should not be given COVID-19 vaccine now: Health ministry

The ministry has listed precautions and contraindications for COVID-19 vaccination along with a comparative factsheet for both the vaccines

15 Jan 2021 10:32 AM

The PMO statement said the vaccination programme is based on principles of priority groups to be vaccinated first. (PTI/file)

PM Modi to launch COVID-19 vaccination drive on January 16

Modi is likely to interact via video link with some healthcare workers fwho will be receiving the shots on the first day

15 Jan 2021 9:17 AM

Drugs Controller General of India Dr V G Somani along with Principal Director General of Press Information Bureau K S Dhatwalia (R) during a press conference to announce the approval of Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, in New Delhi, Sunday, Jan. 03, 2021. (PTI)

Covishield to cost Rs.200 per dose, export banned by government

The government is now in a hurry to start vaccination drive, the schedule for which will be announced soon

05 Jan 2021 7:23 AM

Bharat Biotech aims to recruit 26,000 volunteers across the country for the Phase-3 trials; it has crossed the 23,000-volunteer mark. (AFP)

Vaccine makers call approval a giant leap

SII has stockpiled around 5 crore dosages of the vaccine and aims to produce up to 10 crore per month by March next year

04 Jan 2021 11:22 AM

India has authorised the emergency use of two coronavirus vaccines developed by AstraZeneca and Oxford University and by local pharmaceutical firm Bharat Biotech, the country's drug regulator said Sunday. (Representational Image: PTI)

DCGI approves two Covid-19 vaccines for emergency use

The approval is expected to kick off one of the world's biggest vaccination drives in coming days in the country of 1.3 billion people

03 Jan 2021 11:54 AM

Bharat Biotech has submitted data from Phase 1 and 2 trials to the CDSCO and the Drugs Controller General of India (Representational Image: AFP)

Nod for vaccines amid scare over new strains of Covid-19

Subject Expert Committee of the CDSCO granted permission to Bharat Biotech in the ‘clinical trial’ mode and with ‘abundant precaution

03 Jan 2021 4:43 AM

Covishield has been recommended based on the human trial results in the the United Kingdom, the United States of America and India (Representational Image: AFP)

Covishield moves closer to approval

The recommendation on Covishield has been forwarded to the Drugs Controller General of India, which is likely to take a final call soon

02 Jan 2021 12:36 AM

-1 of 3

Columns

Shikha Mukerjee

MOST POPULAR

1

2

3

4

5

Columns